Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 USD | -4.09% | -3.37% | -36.30% |
05-15 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.30% | 3.42M | |
-7.16% | 177B | |
-4.86% | 65.54B | |
-4.28% | 47.09B | |
+10.32% | 43.43B | |
+8.14% | 41.77B | |
+15.76% | 29.55B | |
+15.53% | 24.83B | |
-5.88% | 23.97B | |
-5.38% | 23.54B |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- Earnings Flash (INVO) INVO BIOSCIENCE Posts Q1 Revenue $348,025, vs. Street Est of $374,000